Resultados de la búsqueda 471-480 of 13928 for Raised platelets

1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   ... high (80-90%) frequency of MUC1 expression and variably high ... platelets ≥ 100,000 /microliter, performed within 7 days prior to the collection.

2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   ... high (80-90%) frequency of MUC1 expression and variably high ... platelets ≥ 100,000 /microliter, performed within 7 days prior to the collection.

3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   ... high (80-90%) frequency of MUC1 expression and variably high ... platelets ≥ 100,000 /microliter, performed within 7 days prior to the collection.

4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   ... high (80-90%) frequency of MUC1 expression and variably high ... platelets ≥ 100,000 /microliter, performed within 7 days prior to the collection.

5. Cirugía - Ensayos clínicos - Mayo Clinic

   This study aims to prevent the deaths and suffering associated with venous thromboembolism and bleeding by identifying the individual person at high risk of ...

6. Mayo Clinic Cardiovascular Physician Update - May 2024

   Page 1.

7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   ... high (80-90%) frequency of MUC1 expression and variably high ... platelets ≥ 100,000 /microliter, performed within 7 days prior to the collection.

8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   ... high (80-90%) frequency of MUC1 expression and variably high ... platelets ≥ 100,000 /microliter, performed within 7 days prior to the collection.

9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   ... high-risk (IPI 3 to 5), a-BCL. Testing The Addition Of Abemaciclib To ... high risk for developing CRCT identified prior to the onset of therapy.

10. Hematología - Ensayos clínicos - Mayo Clinic

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic ...